Skip to content

NEXI Biotech Inc

Plug and Play · NEXI Biotech develops in vitro neurotechnology models for improved neurological drug discovery and translation.

Competitors

Adjacent

Also from Plug and Play

All of Plug and Play

Programs

Programs NEXI Biotech Inc went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About NEXI Biotech Inc

NEXI Biotech Inc is an innovative lifetech company focused on advancing neurological drug discovery through in vitro neurotechnology models. By engineering human iPSC-derived brain circuits on high-density microelectrode arrays, NEXI generates high-resolution, spatiotemporal electrophysiological data at single-cell resolution. This approach addresses the limitations of traditional animal models and static organoids, which often yield misleading efficacy signals contributing to high clinical failure rates in CNS drug development. NEXI’s platform measures emergent circuit dynamics within a canonical cortical-striatal-thalamic architecture, applicable to a broad range of neurodegenerative, neurodevelopmental, and neuropsychiatric diseases. The technology has supported multiple investigational new drug applications by providing human cell-based efficacy data, enhancing translational predictability. Offering a flexible business model that includes fee-for-service and licensing arrangements, NEXI Biotech provides scalable solutions to reduce risk and improve outcomes in CNS therapeutic development, representing a significant innovation in neuropharmacology and drug validation.

Category
Other
Location
United States
Checked
3h ago

NEXI Biotech Inc: questions

Which accelerators did NEXI Biotech Inc go through?

NEXI Biotech Inc is listed by Plug and Play.

Where is NEXI Biotech Inc based?

NEXI Biotech Inc lists United States as its location on Plug and Play's page.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.